Cancer cell-derived clusterin modulates the phosphatidylinositol 3′-kinase-Akt pathway through attenuation of insulin-like growth factor 1 during serum deprivation

Molecular and Cellular Biology

Volumn 28, Issue 13, 2008, Pages 4285-4299

  Jo, Hakryul ^a   Jia, Yonghui ^a   Subramanian, Kulandayan K ^a   Hattori, Hidenori ^a   Luo, Hongbo R ^a  

^a Karp Family Research Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELL PROLIFERATION; CLUSTERIN; CULTURE MEDIA, SERUM-FREE; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; ZEBRAFISH;

EID: 46149112156     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01240-07     Document Type: Article

References (51)

1. Alt-Holland, A., W. Zhang, A. Margulis, and J. A. Garlick. 2005. Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Semin. Cancer Biol. 15:84-96.
2. Bader, A. G., S. Kang, L. Zhao, and P. K. Vogt. 2005. Oncogenic PI3K deregulates transcription and translation. Nat. Rev. Cancer 5:921-929.
3. Baek, J. H., J. E. Jang, C. M. Kang, H. Y. Chung, N. D. Kim, and K. W. Kim. 2000. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 19:4621-4631.
4. Barcellos-Hoff, M. H., and S. A. Ravani. 2000. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60:1254-1260.
5. Bettuzzi, S., F. Scorcioni, S. Astancolle, P. Davalli, M. Scaltriti, and A. Corti. 2002. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21:4328-4334.
6. Bhowmick, N. A., E. G. Neilson, and H. L. Moses. 2004. Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337.
7. Bjork, J. K., and L. Sistonen. 2006. Clustering of heat-shock factors. Biochem. J. 395:e5-e6.
8. Brazil, D. P., and B. A. Hemmings. 2001. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:657-664.
9. Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296:1655-1657.
10. Criswell, T., M. Beman, S. Araki, K. Leskov, E. Cataldo, L. D. Mayo, and D. A. Boothman. 2005. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a prosurvival factor. J. Biol. Chem. 280:14212-14221.
11. Das, B., H. Yeger, R. Tsuchida, R. Torkin, M. F. Gee, P. S. Thorner, M. Shibuya, D. Malkin, and S. Baruchel. 2005. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Cancer Res. 65:7267-7275.
12. Desbois-Mouthon, C., W. Cacheux, M. J. Blivet-Van Eggelpoel, V. Barbu, L. Fartoux, R. Poupon, C. Housset, and O. Rosmorduc. 2006. Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. Int. J. Cancer 119:2557-2566.
13. Engelman, J. A., J. Luo, and L. C. Cantley. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7:606-619.
14. Fei, Z. L., C. D'Ambrosio, S. Li, E. Surmacz, and R. Baserga. 1995. Association of insulin receptor substrate 1 with simian virus 40 large T antigen. Mol. Cell. Biol. 15:4232-4239.
15. Gatenby, R. A., E. T. Gawlinski, A. F. Gmitro, B. Kaylor, and R. J. Gillies. 2006. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 66:5216-5223.
16. Gatenby, R. A., and R. J. Gillies. 2004. Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4:891-899.
17. Gleave, M., and K. N. Chi. 2005. Knock-down of the cytoprotective gene, clusterin, to enhance hormone and chemosensitivity in prostate and other cancers. Ann. N. Y. Acad. Sci. 1058:1-15.
18. Han, B. H., R. B. DeMattos, L. L. Dugan, J. S. Kim-Han, R. P. Brendza, J. D. Fryer, M. Kierson, J. Cirrito, K. Quick, J. A. Harmony, B. J. Aronow, and D. M. Holtzman. 2001. Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat. Med. 7:338-343.
19. Hanada, M., J. Feng, and B. A. Hemmings. 2004. Structure, regulation and function of PKB/AKT: a major therapeutic target. Biochim. Biophys. Acta 1697:3-16.
20. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
21. Hennessy, B. T., D. L. Smith, P. T. Ram, Y. Lu, and G. B. Mills. 2005. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4:988-1004.
22. Hill, M. M., S. F. Clark, D. F. Tucker, M. J. Birnbaum, D. E. James, and S. L. Macaulay. 1999. A role for protein kinase Bβ/Akt2 in insulin-stimulated GLUT4 translocation in adipocytes. Mol. Cell. Biol. 19:7771-7781.
23. Hill, R., Y. Song, R. D. Cardiff, and T. Van Dyke. 2005. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 123:1001-1011.
24. Hurbin, A., J. L. Coll, L. Dubrez-Daloz, B. Mari, P. Auberger, C. Brambilla, and M. C. Favrot. 2005. Cooperation of amphiregulin and insulin-like growth factor-1 inhibits Bax- and Bad-mediated apoptosis via a protein kinase C-dependent pathway in non-small cell lung cancer cells. J. Biol. Chem. 280:19757-19767.
25. Hurbin, A., L. Dubrez, J. L. Coll, and M. C. Favrot. 2003. Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines. Ann. N. Y. Acad. Sci. 1010:354-357.
26. Jo, H., R. Zhang, H. Zhang, T. A. McKinsey, J. Shao, R. D. Beauchamp, D. W. Ballard, and P. Liang. 2000. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis. Oncogene 19:841-849.
27. Karey, K. P., and D. A. Sirbasku. 1988. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Cancer Res. 48:4083-4092.
28. Lakins, J., S. A. Bennett, J. H. Chen, J. M. Arnold, C. Morrissey, P. Wong, J. O'Sullivan, and M. Tenniswood. 1998. Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate. J. Biol. Chem. 273:27887-27895.
29. Lau, S. H., J. S. Sham, D. Xie, C. H. Tzang, D. Tang, N. Ma, L. Hu, Y. Wang, J. M. Wen, G. Xiao, W. M. Zhang, G. K. Lau, M. Yang, and X. Y. Guan. 2006. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 25:1242-1250.
30. Leskov, K. S., D. Y. Klokov, J. Li, T. J. Kinsella, and D. A. Boothman. 2003. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278:11590-11600.
31. Liang, J., J. Zubovitz, T. Petrocelli, R. Kotchetkov, M. K. Connor, K. Han, J. H. Lee, S. Ciarallo, C. Catzavelos, R. Beniston, E. Franssen, and J. M. Slingerland. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat. Med. 8:1153-1160.
32. Luo, H. R., H. Hattori, M. A. Hossain, L. Hester, Y. Huang, W. Lee-Kwon, M. Donowitz, E. Nagata, and S. H. Snyder. 2003. Akt as a mediator of cell death. Proc. Natl. Acad. Sci. USA 100:11712-11717.
33. Ma, Y., and L. M. Hendershot. 2004. ER chaperone functions during normal and stress conditions. J. Chem. Neuroanat. 28:51-65.
34. Maiorano, E., A. Ciampolillo, G. Viale, P. Maisonneuve, A. Ambrosi, V. Triggiani, E. Marra, and E. Perlino. 2000. Insulin-like growth factor 1 expression in thyroid tumors. Appl. Immunohistochem. Mol. Morphol. 8:110-119.
35. Mueller, M. M., and N. E. Fusenig. 2004. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4:839-849.
36. Orimo, A., P. B. Gupta, D. C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V. J. Carey, A. L. Richardson, and R. A. Weinberg. 2005. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348.
37. Pollak, M. N., E. S. Schernhammer, and S. E. Hankinson. 2004. Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4:505-518.
38. Prisco, M., F. Santini, R. Baffa, M. Liu, R. Drakas, A. Wu, and R. Baserga. 2002. Nuclear translocation of insulin receptor substrate-1 by the simian virus 40 T antigen and the activated type 1 insulin-like growth factor receptor. J. Biol. Chem. 277:32078-32085.
39. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
40. Shachaf, C. M., and D. W. Felsher. 2005. Tumor dormancy and MYC inactivation: pushing cancer to the brink of normalcy. Cancer Res. 65:4471-4474.
41. Shannan, B., M. Seifert, K. Leskov, J. Willis, D. Boothman, W. Tilgen, and J. Reichrath. 2006. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 13:12-19.
42. Shin, I., F. M. Yakes, F. Rojo, N. Y. Shin, A. V. Bakin, J. Baselga, and C. L. Arteaga. 2002. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145-1152.
43. Spencer, S. L., R. A. Gerety, K. J. Pienta, and S. Forrest. 2006. Modeling somatic evolution in tumorigenesis. PLoS Comput. Biol. 2:8.
44. Subramanian, K. K., Y. Jia, D. Zhu, B. T. Simms, H. Jo, H. Hattori, J. You, J. P. Mizgerd, and H. R. Luo. 2007. Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood 109:4028-4037.
45. Thomas-Tikhonenko, A., I. Viard-Leveugle, M. Dews, P. Wehrli, C. Sevignani, D. Yu, S. Ricci, W. el-Deiry, B. Aronow, G. Kaya, J. H. Saurat, and L. E. French. 2004. Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res. 64:3126-3136.
46. Vivanco, I., and C. L. Sawyers. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489-501.
47. Watton, S. J., and J. Downward. 1999. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol. 9:433-436.
48. Wehrli, P., Y. Charnay, P. Vallet, G. Zhu, J. Harmony, B. Aronow, J. Tschopp, C. Bouras, I. Viard-Leveugle, L. E. French, and P. Giannakopoulos. 2001. Inhibition of post-ischemic brain injury by clusterin overexpression. Nat. Med. 7:977-979.
49. Zhang, H., J. K. Kim, C. A. Edwards, Z. Xu, R. Taichman, and C. Y. Wang. 2005. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7:909-915.
50. Zhou, W., L. Janulis, I. I. Park, and C. Lee. 2002. A novel anti-proliferative property of clusterin in prostate cancer cells. Life Sci. 72:11-21.
51. Zhu, W., J. Chen, X. Cong, S. Hu, and X. Chen. 2006. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24:416-425.